The released AT, in response to overproduced ROS, could optimize the lipid profiles and reduce atherosclerosis through decreasing the number of perivascular CD31+ neovessels and inhibiting the KI67+ endothelial proliferations. The gene discussed is PECAM1; the disease is atherosclerosis.